Cargando…

The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma

Background: Cuproptosis has been recognized as a novel regulatory cell death, which has been confirmed to promote the occurrence and development of tumors. However, whether cuproptosis-related lncRNA has an impact on the prognosis of squamous cell carcinoma of the head and neck (HNSCC) is still uncl...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yao jun, Li, Hai yan, Zhang, Quan, Wei, Sheng li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356288/
https://www.ncbi.nlm.nih.gov/pubmed/35942287
http://dx.doi.org/10.3389/fgene.2022.942785
_version_ 1784763484164063232
author Li, Yao jun
Li, Hai yan
Zhang, Quan
Wei, Sheng li
author_facet Li, Yao jun
Li, Hai yan
Zhang, Quan
Wei, Sheng li
author_sort Li, Yao jun
collection PubMed
description Background: Cuproptosis has been recognized as a novel regulatory cell death, which has been confirmed to promote the occurrence and development of tumors. However, whether cuproptosis-related lncRNA has an impact on the prognosis of squamous cell carcinoma of the head and neck (HNSCC) is still unclear. Methods: In total, 501 HNSCC tumor samples and 44 normal were downloaded from the TCGA database. Cuproptosis-related lncRNAs were obtained by co-expressed analysis. We got prognostic lncRNA that was associated with cuproptosis by using univariate Cox regression analysis and LASSO Cox regression. Then we constructed and validated the prognostic signature of HNSCC and analyzed the immune landscape of the signature. Results: The Prognostic Signature is based on 10 cuproptosis-related lncRNAs including AC090587.1, AC004943.2, TTN-AS1, AL162458.1, AC106820.5, AC012313.5, AL132800.1, WDFY3-AS2, CDKN2A-DT, and AL136419.3. The results of overall survival, risk score distribution, and survival status in the low-risk group were better than those in the high-risk group. In addition, all immune checkpoint genes involved were significantly different between the two risk groups (p < 0.05). The risk score was positively correlated with Eosinophils. M0 and M2 phenotype macrophages, mast cells activated, NK cells activated, and negatively related with B cells naive, mast cells resting, plasma cells, CD8T cells, T cells follicular helper, T cells regulatory (Tregs). Consensus clustering was identified in molecular subtypes of HNSC. More high-risk samples concentrated in Cluster1, which had a higher Tumor Immune Dysfunction and Exclusion (TIDE) score and Single Nucleotide Polymorphisms (SNP) alternation than Cluster2. Conclusion: Our study elucidated the correlation between cuproptosis-related lncRNA with prognosis and immune landscape of HNSCC, which may provide references for further research on the exploration of the mechanism and functions of the prognosis for HNSCC.
format Online
Article
Text
id pubmed-9356288
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93562882022-08-07 The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma Li, Yao jun Li, Hai yan Zhang, Quan Wei, Sheng li Front Genet Genetics Background: Cuproptosis has been recognized as a novel regulatory cell death, which has been confirmed to promote the occurrence and development of tumors. However, whether cuproptosis-related lncRNA has an impact on the prognosis of squamous cell carcinoma of the head and neck (HNSCC) is still unclear. Methods: In total, 501 HNSCC tumor samples and 44 normal were downloaded from the TCGA database. Cuproptosis-related lncRNAs were obtained by co-expressed analysis. We got prognostic lncRNA that was associated with cuproptosis by using univariate Cox regression analysis and LASSO Cox regression. Then we constructed and validated the prognostic signature of HNSCC and analyzed the immune landscape of the signature. Results: The Prognostic Signature is based on 10 cuproptosis-related lncRNAs including AC090587.1, AC004943.2, TTN-AS1, AL162458.1, AC106820.5, AC012313.5, AL132800.1, WDFY3-AS2, CDKN2A-DT, and AL136419.3. The results of overall survival, risk score distribution, and survival status in the low-risk group were better than those in the high-risk group. In addition, all immune checkpoint genes involved were significantly different between the two risk groups (p < 0.05). The risk score was positively correlated with Eosinophils. M0 and M2 phenotype macrophages, mast cells activated, NK cells activated, and negatively related with B cells naive, mast cells resting, plasma cells, CD8T cells, T cells follicular helper, T cells regulatory (Tregs). Consensus clustering was identified in molecular subtypes of HNSC. More high-risk samples concentrated in Cluster1, which had a higher Tumor Immune Dysfunction and Exclusion (TIDE) score and Single Nucleotide Polymorphisms (SNP) alternation than Cluster2. Conclusion: Our study elucidated the correlation between cuproptosis-related lncRNA with prognosis and immune landscape of HNSCC, which may provide references for further research on the exploration of the mechanism and functions of the prognosis for HNSCC. Frontiers Media S.A. 2022-07-22 /pmc/articles/PMC9356288/ /pubmed/35942287 http://dx.doi.org/10.3389/fgene.2022.942785 Text en Copyright © 2022 Li, Li, Zhang and Wei. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Li, Yao jun
Li, Hai yan
Zhang, Quan
Wei, Sheng li
The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
title The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
title_full The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
title_fullStr The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
title_full_unstemmed The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
title_short The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
title_sort prognostic value and immune landscape of a cuproptosis-related lncrna signature in head and neck squamous cell carcinoma
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356288/
https://www.ncbi.nlm.nih.gov/pubmed/35942287
http://dx.doi.org/10.3389/fgene.2022.942785
work_keys_str_mv AT liyaojun theprognosticvalueandimmunelandscapeofacuproptosisrelatedlncrnasignatureinheadandnecksquamouscellcarcinoma
AT lihaiyan theprognosticvalueandimmunelandscapeofacuproptosisrelatedlncrnasignatureinheadandnecksquamouscellcarcinoma
AT zhangquan theprognosticvalueandimmunelandscapeofacuproptosisrelatedlncrnasignatureinheadandnecksquamouscellcarcinoma
AT weishengli theprognosticvalueandimmunelandscapeofacuproptosisrelatedlncrnasignatureinheadandnecksquamouscellcarcinoma
AT liyaojun prognosticvalueandimmunelandscapeofacuproptosisrelatedlncrnasignatureinheadandnecksquamouscellcarcinoma
AT lihaiyan prognosticvalueandimmunelandscapeofacuproptosisrelatedlncrnasignatureinheadandnecksquamouscellcarcinoma
AT zhangquan prognosticvalueandimmunelandscapeofacuproptosisrelatedlncrnasignatureinheadandnecksquamouscellcarcinoma
AT weishengli prognosticvalueandimmunelandscapeofacuproptosisrelatedlncrnasignatureinheadandnecksquamouscellcarcinoma